Provided by Tiger Fintech (Singapore) Pte. Ltd.

LUYE PHARMA

3.810
-0.070-1.80%
Volume:37.24M
Turnover:142.33M
Market Cap:14.82B
PE:27.75
High:3.880
Open:3.870
Low:3.770
Close:3.880
52wk High:4.490
52wk Low:1.670
Shares:3.89B
HK Float Shares:3.89B
Volume Ratio:0.47
T/O Rate:0.96%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.137
ROE:3.68%
ROA:2.09%
PB:0.92
PE(LYR):27.75
PS:2.19

Loading ...

LUYE PHARMA (02186) Issues 52.92 Million Shares Due to Convertible Bond Conversion

Stock News
·
53 mins ago

Luye Pharma Group's H1 Profit Falls 19%

MT Newswires Live
·
Aug 29

Stock Track | Luye Pharma Soars 5.69% Following Strong H1 2025 Financial Results

Stock Track
·
Aug 29

LUYE PHARMA (02186) Reports Interim Results with Shareholders' Profit of RMB313 Million, Down 19.33% YoY

Stock News
·
Aug 28

BRIEF-Luye Pharma Posts HY Profit Attributable Of RMB312.9 Mln

Reuters
·
Aug 28

Luye Pharma - Profit Attributable for Six Months RMB312.9 Mln

THOMSON REUTERS
·
Aug 28

Luye Pharma Group H1 Gross Margin 67.8%

THOMSON REUTERS
·
Aug 28

Kale Asset Holding Ltd Reduces Stake in LUYE PHARMA (02186) by 11.25 Million Shares at Average Price of HKD 3.76 Per Share

Stock News
·
Aug 22

LUYE PHARMA (02186) Issues 52.919 Million Shares Due to Convertible Bond Conversion

Stock News
·
Aug 20

Luye Pharma Completes Patient Enrollment for Phase 3 GAD Trial

MT Newswires Live
·
Aug 18

LUYE PHARMA (02186): Ruoxinlin® Phase III Clinical Trial for Generalized Anxiety Disorder Completes Patient Enrollment in China

Stock News
·
Aug 18

Luye Pharma Group Ltd. Announces Conversion of Tranche A Bonds Worth US$10 Million

Reuters
·
Aug 01

Shandong Boan Biotechnology Co. Ltd. Receives FDA Approval to Initiate Clinical Trials for BA1302 in the U.S

Reuters
·
Jun 17

Luye Pharma Group Ltd. Conducted Annual General Meeting

Reuters
·
May 28

Hong Kong Stocks Reverse Early Losses to End Higher; Pharma Stocks Slide

MT Newswires Live
·
Apr 09

Hong Kong Pharma Stocks Decline as Trump Threatens Tariffs on Imported Drugs

MT Newswires Live
·
Apr 09

Luye Pharma Gets Macao Approval for Antidepressant

MT Newswires Live
·
Apr 08

BRIEF-Luye Pharma Says Antidepressant Ruoxinlin Approved For Marketing In Macao

Reuters
·
Apr 07

Luye Pharma Group Rivastigmine Patch Approved for Alzheimer's Treatment in Japan

MT Newswires Live
·
Apr 01